Literature DB >> 12776987

The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation.

Cecilia Annerén1, Cecilia K Lindholm, Vitezslav Kriz, Michael Welsh.   

Abstract

Recent experiments have unravelled novel signal transduction pathways that involve the SRC homology 2 (SH2) domain adapter protein SHB. SHB is ubiquitously expressed and contains proline rich motifs, a phosphotyrosine binding (PTB) domain, tyrosine phosphorylation sites and an SH2 domain and serves a role in generating signaling complexes in response to tyrosine kinase activation. SHB mediates certain responses in platelet-derived growth factor (PDGF) receptor-, fibroblast growth factor (FGF) receptor-, neural growth factor (NGF) receptor TRKA-, T cell receptor-, interleukin-2 (IL-2) receptor- and focal adhesion kinase- (FAK) signaling. Upstream of SHB in some cells lies the SRC-like FYN-Related Kinase FRK/RAK (also named BSK/IYK or GTK). FRK/RAK and SHB exert similar effects when overexpressed in rat phaeochromocytoma (PC12) and beta-cells, where they both induce PC12 cell differentiation and beta-cell proliferation. Furthermore, beta-cell apoptosis is augmented by these proteins under conditions that cause beta-cell degeneration. The FRK/RAK-SHB responses involve FAK and insulin receptor substrates (IRS) -1 and -2. Besides regulating apoptosis, proliferation and differentiation, SHB is also a component of the T cell receptor (TCR) signaling response. In Jurkat T cells, SHB links several signaling components with the TCR and is thus required for IL-2 production. In endothelial cells, SHB both promotes apoptosis under conditions that are anti-angiogenic, but is also required for proper mitogenicity, spreading and tubular morphogenesis. In embryonic stem cells, dominant-negative SHB (R522K) prevents early cavitation of embryoid bodies and reduces differentiation to cells expressing albumin, amylase, insulin and glucagon, suggesting a role of SHB in development. In summary, SHB is a versatile signal transduction molecule that produces diverse biological responses in different cell types under various conditions. SHB operates downstream of GTK in cells that express this kinase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776987     DOI: 10.2174/1566524033479744

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  21 in total

1.  Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.

Authors:  Bo Sun; Nan Yang; Yao Jiang; Huifeng Zhang; Chunying Hou; Chao Ji; Yanyong Liu; Pingping Zuo
Journal:  Tumour Biol       Date:  2015-03-18

2.  FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.

Authors:  Lei Hua; Ming Zhu; Xu Song; Jun Wang; Zhen Fang; Chunting Zhang; Qiong Shi; Wenjian Zhan; Lei Wang; Qingming Meng; Xiuping Zhou; Rutong Yu
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

3.  The SH2 domain-containing proteins in 21 species establish the provenance and scope of phosphotyrosine signaling in eukaryotes.

Authors:  Bernard A Liu; Eshana Shah; Karl Jablonowski; Andrew Stergachis; Brett Engelmann; Piers D Nash
Journal:  Sci Signal       Date:  2011-12-06       Impact factor: 8.192

4.  Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis.

Authors:  Björn Åkerblom; Guangxiang Zang; Zhen W Zhuang; Gabriela Calounova; Michael Simons; Michael Welsh
Journal:  Mol Oncol       Date:  2012-01-31       Impact factor: 6.603

5.  Development of an ischemic tolerance model in a PC12 cell line.

Authors:  Joëlle A Hillion; Kenzo Takahashi; Dragan Maric; Christl Ruetzler; Jeffery L Barker; John M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2005-02       Impact factor: 6.200

6.  The Src homology 2 domain-containing adapter protein B (SHB) regulates mouse oocyte maturation.

Authors:  Gabriela Calounova; Gabriel Livera; Xiao-Qun Zhang; Kui Liu; Roger G Gosden; Michael Welsh
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

Review 7.  RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Cell Cycle       Date:  2009-09-29       Impact factor: 4.534

8.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Authors:  Eun-Kyoung Yim; Guang Peng; Hui Dai; Ruozhen Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T Hennessy; Rolf J Craven; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

9.  Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.

Authors:  Gustaf Christoffersson; Guangxiang Zang; Zhen W Zhuang; Evelina Vågesjö; Michael Simons; Mia Phillipson; Michael Welsh
Journal:  Angiogenesis       Date:  2012-05-05       Impact factor: 9.596

10.  FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling.

Authors:  Xiuping Zhou; Lei Hua; Weijian Zhang; Ming Zhu; Qiong Shi; Feng Li; Liexiang Zhang; Chao Song; Rutong Yu
Journal:  J Neurooncol       Date:  2012-07-13       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.